OBJECTIVES: Colorectal cancer and gastric cancer are one of the most prevalent types of cancer and are leading causes of cancer-related mortality worldwide. The chemotherapy is insufficient due to the poor targeting and affinity of drugs, low therapeutic effectiveness, and significant side effects. Consequently, developing effective therapeutic formulations is crucial for treating colorectal and gastric cancers. METHODS: This study aims to evaluate the antiproliferative activity of RESULTS: The results demonstrate a dose-dependent anticancer effect of CONCLUSIONS: In conclusion, the